NCT05895279

Assessment of Research Digest Impact for Minority with Prostate Cancer, MiCAP Phase III Study

Minority Prostate Cancer (MiCaP) Phase III (Aim 3): Assessment of Research Digest Impact

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 220 (actual)
• Sponsor: Mayo Clinic · Academic / Other
• Sex: Male
• Age: 35 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

This phase III trial determines how well the Minority Prostate Cancer (MiCaP) Research Digest works in providing information to black men about the latest prostate cancer research. MiCaP Research Digest may be an effective method to help people learn about prostate cancer.This goal of this trial is to create educational programming that helps Black men make informed decisions about their prostate healthcare since Black men are diagnosed with prostate cancer more than any other race or ethnicity.

Detailed description

PRIMARY OBJECTIVE: I. To develop a research dissemination program, the Minority Prostate Cancer (MiCaP) Research Digest, which will spread information about CaP scientific discoveries, evidence-based interventions, and open clinical trials instantly among black males (BM). OUTLINE: Participants are randomized to 1 of 2 arms. ARM I: Participants watch MiCaP Research Digest video on study. Participants complete a survey throughout the trial. ARM II: Participants watch an alternative video on study. Participants complete a survey throughout the trial.

Conditions

• Prostate Carcinoma

Interventions

Type	Name	Description
OTHER	Media Intervention	Watch MiCaP Research Digest video
OTHER	Media Intervention	Watch alternate video
OTHER	Survey Administration	Complete survey

Timeline

• Start date: 2021-08-02
• Primary completion: 2021-10-01
• Completion: 2021-10-01
• First posted: 2023-06-08
• Last updated: 2024-11-04

Locations

1 site across 1 country: United States